Butyrate 'Trains' Gut Cells for Lasting Protection — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Northwestern Medicine researchers found that butyrate, a short-chain fatty acid produced when gut bacteria break down dietary fiber, reprograms intestinal epithelial cells so they keep driving anti-inflammatory immune responses even after the compound is no longer present.
- Mice given butyrate in their drinking water were more resistant to chemically induced colitis, showing less weight loss, lower inflammatory markers, and less severe tissue damage than untreated animals — protection that persisted two weeks after treatment ended.
- The lasting effect depended on IL-10 signaling and was reproduced in germ-free mice, indicating the imprint does not rely on continuous microbial stimulation or shifts in the gut microbiome's composition.
- Mechanistically, butyrate triggered sustained transcriptional and epigenetic activation of the Sat1 gene in intestinal epithelial cells, producing the metabolite N1-acetylspermidine, which increased IL-10 production in both mouse and human T-cells in lab cultures.
- N1-acetylspermidine alone accounted for only part of the immune-regulating activity released by butyrate-treated epithelial cells, leaving open the possibility that additional unidentified metabolites contribute to the effect.
- First and co-corresponding author Tianming Yu, PhD, of Northwestern's Division of Gastroenterology and Hepatology, said the team's next step is testing whether the same butyrate-Sat1-N1-acetylspermidine pathway operates in patients with inflammatory bowel disease.
Why it matters: For patients with inflammatory bowel disease, existing drugs broadly suppress the immune system. If the butyrate-Sat1-N1-acetylspermidine pathway operates in human intestinal cells the same way it did in mice, it could eventually open a path to dietary or metabolite-based interventions that promote tolerance rather than blanket suppression — but the researchers themselves emphasize the work is preclinical and unconfirmed in people.
Ask SkimNews
